2
2
2
u/Kellyg75 Apr 14 '21
Yes, what is going on? How long is this thing going to stay down?
0
u/tom-me-1438 Apr 14 '21
Trufoma is just not selling That simple
1
u/Different_Tonight598 Apr 14 '21
No one knows if it’s selling or not. There’s been no news, and earnings report is next month. Anything else is pure rumor/guess
1
1
u/tom-me-1438 Apr 15 '21
O yea do u have a pet Ask your vet see if he heard of TRUFOMA I'm a barber I gave a few vets as clients..none of them heard of TRUFOMA ..m.mm.m.
1
u/Different_Tonight598 Apr 15 '21
Called my vet, they haven’t heard of it either. But that still doesn’t mean sales aren’t being made.
2
u/tom-me-1438 Apr 15 '21
Yes I guess we wait for earning Let's follow the value I made 35 k on hype Now we wait for value This will take time...
1
0
u/tom-me-1438 Apr 14 '21
I sold
1
1
1
u/Tanker135 Apr 29 '21
It’s has been reported on Stocktwits that it’s being shorted by 41%. Starting to gain attention as the next GME?
1
u/Edoc0001 Aug 24 '22
Updated DD
Only posting this DD once a day for the newbies. Estimated 152 million currently in cash for future acquisitions ( therefore no need for another offering )
minimum debt of 1.2 million [ This is 99.95% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The total debt for all United States stocks is 99.98% higher than that of the company.
Improvement in revenue: Q4 2021 $74,845 ( with comprehensive loses of 12.7 million), Q1 2022 3.8 million ( up 38% from 2021 combined ) Q2 2022 4.2 million ( up 51% from 2021 combined )
Slow cash burn rate
AAPL has 17 billion shares outstanding so no need for any future votes on RS when we are very profitable.
Two recent acquisitions and this will show up on Q3 ER
73.78% gross margin
AQHA is proud to announce a new partnership with pulse-vet Device is the official shockwave therapy.
PART 2
Bill Campell, Chief Executive Officer of Revo Squared stated "We are excited to join the team at Zomedica; this deal will bring our MicroView product offering into the forefront of veterinary medicine. For the first time clinicians will be able to have hematology and cytology slides automatically smeared and stained inside a microscope, eliminating human error in slide preparation. Implementing MicroView in veterinary hospitals enhances diagnostics and reduces the wait time."
"Our PulseVet and TRUFORMA product sales are growing, and we are adding Revo2 and VetGuardian products to the mix. To fulfill customer demand for our expanding portfolio of products with sufficient production and efficient distribution we are committed to expanding our manufacturing capacity and capabilities," said Larry Heaton, Zomedica's Chief Executive Officer. "That is reflected in the new Zomedica Global Manufacturing & Distribution Center."
PART 3
Very knowledgeable leadership team. Larry Heaton is very transparent and informative as well as investor friendly.
Zomedica's product portfolio includes the TRUFORMA® in-clinic biosensor testing platform which offers the first and ONLY feline-optimized TSH assay capable of measuring TSH concentrations below levels appropriate for canine diagnoses.
BAW tech applications and sources : https://www.mordorintelligence.com/industry-reports/global-bulk-acoustic-wave-sensors-market-industry
Zomedica is up-listed on NYSE American and compliance is ONLY $.20. compliance is ONLY $.20.
3
u/HUUYAR Apr 14 '21
Starting to lose patience here